Literature DB >> 6991425

Influence of serum concentration on opsonization by the classical and alternative complement pathways.

R W Tofte, P K Peterson, Y Kim, P G Quie.   

Abstract

In this investigation of bacterial opsonization by the serum complement system, the importance of using various serum concentrations and of performing kinetic studies is demonstrated.

Mesh：

Substances：

Year:  1980        PMID： 6991425      PMCID： PMC550821          DOI： 10.1128/iai.27.2.693-696.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Evidence for quantitative variability of bacterial opsonic requirements.

Authors:  J C Guckian; W D Christensen; D P Fine
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.

Authors:  P Stevens; S N Huang; W D Welch; L S Young
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

5.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

6.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

7.  Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.

Authors:  H E Jasin
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

8.  Complement-mediated phagocytosis of Pseudomonas aeruginosa.

Authors:  P K Peterson; Y Kim; D Schmeling; M Lindemann; J Verhoef; P G Quie
Journal:  J Lab Clin Med       Date:  1978-12

9.  Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.

Authors:  B Björkstén; R Bortolussi; L Gothefors; P G Quie
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

10.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441
View more
  11 in total

1.  Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence.

Authors:  C S Munro; P J Stanley; P J Cole
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

2.  Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.

Authors:  A J Williams; M J Hastings; C S Easmon; P J Cole
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

3.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

4.  Complement consumption gonococcal peptidoglycan.

Authors:  B H Petersen; R S Rosenthal
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

5.  Opsonizing antibodies against pneumococci detected by enhanced NBT. Reduction of phagocytizing granulocytes.

Authors:  T Urban; C Jarstrand; G Tunevall
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

6.  Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.

Authors:  O Nived; C Linder; H Odeberg; B Svensson
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

7.  Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.

Authors:  K K Matthay; W C Mentzer; D W Wara; H K Preisler; N B Lameris; A J Ammann
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Serum opsonic activity in acute protein-energy malnutrition.

Authors:  G T Keusch; J J Urrutia; O Guerrero; G Castaneda; H Smith
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

9.  In vitro interactions between bacteria, osteoblast-like cells and macrophages in the pathogenesis of biomaterial-associated infections.

Authors:  Guruprakash Subbiahdoss; Isabel C Saldarriaga Fernández; Joana F da Silva Domingues; Roel Kuijer; Henny C van der Mei; Henk J Busscher
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

10.  Toxicity of TiO2 Nanoparticles: Validation of Alternative Models.

Authors:  Mélanie M Leroux; Zahra Doumandji; Laetitia Chézeau; Laurent Gaté; Sara Nahle; Romain Hocquel; Vadim Zhernovkov; Sylvie Migot; Jafar Ghanbaja; Céline Bonnet; Raphaël Schneider; Bertrand H Rihn; Luc Ferrari; Olivier Joubert
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.